Ralliant Corporation (NYSE:RAL) Receives $50.50 Consensus PT from Analysts

Ralliant Corporation (NYSE:RAL) has been assigned an average recommendation of “Moderate Buy” from the twelve brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $50.50.

Several equities research analysts have recently issued reports on the stock. Zacks Research raised shares of Ralliant from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Royal Bank Of Canada decreased their price objective on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a research report on Friday, February 6th. Vertical Research upgraded shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research note on Friday, February 6th. Morgan Stanley reiterated an “overweight” rating and set a $45.00 price target on shares of Ralliant in a research note on Friday, February 6th. Finally, Barclays cut their price target on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research note on Monday, February 9th.

Ralliant Price Performance

Ralliant stock opened at $47.40 on Thursday. The stock has a market cap of $5.30 billion and a P/E ratio of 24.18. The company has a fifty day simple moving average of $43.78 and a 200-day simple moving average of $46.79. Ralliant has a 12-month low of $37.27 and a 12-month high of $57.02. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 23rd. Investors of record on Monday, March 9th were paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.4%. The ex-dividend date was Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is currently 10.20%.

Insider Activity

In related news, Director Kevin E. Bryant purchased 1,250 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were purchased at an average cost of $39.97 per share, for a total transaction of $49,962.50. Following the purchase, the director directly owned 4,653 shares of the company’s stock, valued at $185,980.41. The trade was a 36.73% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Amir A. Kazmi purchased 2,545 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were bought at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the purchase, the senior vice president directly owned 39,699 shares in the company, valued at $1,558,979.73. This represents a 6.85% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 8,145 shares of company stock worth $332,233 over the last three months.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of RAL. Danske Bank A S acquired a new position in Ralliant in the fourth quarter valued at $25,000. Westfuller Advisors LLC acquired a new position in Ralliant in the third quarter valued at $26,000. V Square Quantitative Management LLC acquired a new position in Ralliant in the fourth quarter valued at $26,000. Allworth Financial LP increased its stake in Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after purchasing an additional 293 shares during the period. Finally, Palisade Asset Management LLC acquired a new position in Ralliant in the third quarter valued at $26,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.